iopamidol has been researched along with Fatty Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brindle, K; Earls, J; Haji-Momenian, S; Khati, N; Parkinson, W; Zeman, RK | 1 |
| Assy, N; Djibre, A; Farah, R; Grosovski, M; Marmor, A | 1 |
| Catalano, O; Laghi, F; Maresca, M; Sandomenico, F; Siani, A | 1 |
3 other study(ies) available for iopamidol and Fatty Liver
| Article | Year |
|---|---|
Single-energy non-contrast hepatic steatosis criteria applied to virtual non-contrast images: is it still highly specific and positively predictive?
Topics: Computed Tomography Angiography; Contrast Media; Fatty Liver; Humans; Iopamidol; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Presence of coronary plaques in patients with nonalcoholic fatty liver disease.
Topics: Biomarkers; Case-Control Studies; Contrast Media; Coronary Angiography; Coronary Artery Disease; Fatty Liver; Female; Humans; Iopamidol; Logistic Models; Male; Middle Aged; Prevalence; Prospective Studies; Risk Assessment; Risk Factors; Tomography, X-Ray Computed | 2010 |
Indeterminate, subcentimetric focal liver lesions in cancer patients: additional role of contrast-enhanced ultrasound.
Topics: Adult; Contrast Media; Cysts; Diagnosis, Differential; Fatty Liver; Female; Follow-Up Studies; Hemangioma; Humans; Iopamidol; Liver Diseases; Liver Neoplasms; Male; Phospholipids; Prospective Studies; Sulfur Hexafluoride; Tomography, Spiral Computed; Ultrasonography | 2010 |